Home / News / Alarming Rise in Breast Cancer Prevalence will Lead to Above Average Growth of Breast Biopsy Devices in Emerging Markets: Asia Pacific Market To Progress at a CAGR of 12% During 2016 – 2022

Alarming Rise in Breast Cancer Prevalence will Lead to Above Average Growth of Breast Biopsy Devices in Emerging Markets: Asia Pacific Market To Progress at a CAGR of 12% During 2016 – 2022

The latest market report published by Credence Research  “Global Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022,” the breast biopsy devices market was valued at USD 617.62 Mn in 2015, and is expected to reach USD 1,250.71 Mn by 2022, expanding at a CAGR of 10.6% from 2016 to 2022.

Browse the full report Breast Biopsy Devices Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/breast-biopsy-devices-market

Market Insights
Breast cancer is among the most commonly diagnosed non-skin cancer across the world, with among the highest annual mortality. While the incidence of the disease is increasing at alarming rates in the developing markets, the breast cancer survival prognosis is reported to be con tenuously improving this proving development in the trends of early disease diagnosis and treatment outcomes. Pathological detection of breast cancer has evolved a long way until present with biopsy becoming the standard route of disease detection. With the introduction of minimally invasive biopsy procedures, intimating with fine needle aspiration, the global breast biopsy devices market has witnessed phenomenal growth over the period. Rapidly aging population and the proven correlation of age with the incidence of breast cancer is among the biggest contributors to the breast biopsy devices market. Alarming disease incidence and technological development resulting in rapid adoption of breast biopsy devices and related solutions are observed to be the major market drivers in the developing regions of the world. Introduction of guidance enabled biopsy systems has further facilitated the market development and assisted in containment of breast cancer incidence.

Market Competition Assessment

Te global breast biopsy devices market is consolidated with a few players dominating the major chunk of the market revenue. Players such as Hologic, Mammotome, C.R. Bar, Inc. are identified and recognized as the global market leaders. Other players such as Argon Medical Devices, Becton Dickinson and Company, Sterylab are the promising market players with their established positions in prime market segments.

Key Market Movements

  • Increased preference for minimally invasive biopsies
  • Rapid shift towards guided biopsies
  • Growth in adoption of disposable consumables
Alarming Rise in Breast Cancer Prevalence will Lead to Above Average Growth of Breast Biopsy Devices in Emerging Markets: Asia Pacific Market To Progress at a CAGR of 12% During 2016 – 2022 reviewed on April 1, 2016 by rated 4.9 of 5

Release ID: 1578

About Anuradha Shukla

Check Also

400-400

Global Ultrasound Devices Market is Expected to Reach USD 7,673.8 Mn by 2022 – Credence Research

The latest market report published by Credence Research, Inc. “Global Ultrasound Devices Market – Growth, ...